Incubator Section

Within our incubator, the DrugReKindle project stands out as a prime example of how vision and innovation converge to redefine drug repurposing. By leveraging a clinically validated AI platform, DrugReKindle specializes in the repurposing of existing pharmaceuticals and compounds that previously failed due to efficacy in clinical trials. This approach accelerates the identification of new therapeutic potentials for these compounds, demonstrating our commitment to transforming biomedical research into innovative and concrete therapeutic solutions.

Public Projects

At Chelonia, we partner with leading organizations to transform bold ideas into practical solutions. The publicly funded projects below — supported by the EU (e.g., Horizon Europe) and the Swiss State Secretariat for Education, Research and Innovation (SERI) — showcase our commitment to pioneering research, strategic collaboration, and real-world impact. Each initiative demonstrates our drive to advance science, technology, and sustainability, proving that innovation thrives where ambition meets action. Explore the links to discover how we’re shaping the future—one project at a time.